
News|Articles|December 1, 2006
Drug Watch: Agents in late-stage development for the treatment of ankylosing spondylitis, osteoarthritis, and related pain (December 2006) (PDF)
Review of agents in late-stage development for the treatment of ankylosing spondylitis, osteoarthritis, and related pain (December 2006).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Robyn Crosson, J.D., Navitus Health Solutions
2
Yesafili, an Eylea biosimilar, launches with a price of $1,445
3
Genomic testing nearly triples among Medicare patients, but NGS use remains low
4
Ashley Holzworth-Nash, Pharm.D., Evernorth
5






















